Studies related to vLDL-C and Guggul

Guggulipid For The Treatment Of Hypercholesterolemia: A Randomized Controlled Trial

Effect None
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 103
Sex Both Genders
Age Range 30-44, 45-64
Body Types Overweight
Notes for this study:
In persons with hypercholesterolemia, 1g or 2g of guggulipid (2.5% guggulsterones) daily actually was able to increase LDL-C while not significantly affecting other parameters.